The CO2 stimulus for cerebrovascular reactivity: Fixing inspired concentrations vs. targeting end-tidal partial pressures

Joseph A Fisher, Joseph A Fisher

Abstract

Cerebrovascular reactivity (CVR) studies have elucidated the physiology and pathophysiology of cerebral blood flow regulation. A non-invasive, high spatial resolution approach uses carbon dioxide (CO2) as the vasoactive stimulus and magnetic resonance techniques to estimate the cerebral blood flow response. CVR is assessed as the ratio response change to stimulus change. Precise control of the stimulus is sought to minimize CVR variability between tests, and show functional differences. Computerized methods targeting end-tidal CO2 partial pressures are precise, but expensive. Simpler, improvised methods that fix the inspired CO2 concentrations have been recommended as less expensive, and so more widely accessible. However, these methods have drawbacks that have not been previously presented by those that advocate their use, or those that employ them in their studies. As one of the developers of a computerized method, I provide my perspective on the trade-offs between these two methods. The main concern is that declaring the precision of fixed inspired concentration of CO2 is misleading: it does not, as implied, translate to precise control of the actual vasoactive stimulus - the arterial partial pressure of CO2 The inherent test-to-test, and therefore subject-to-subject variability, precludes clinical application of findings. Moreover, improvised methods imply widespread duplication of development, assembly time and costs, yet lack uniformity and quality control. A tabular comparison between approaches is provided.

Keywords: Cerebrovascular reactivity; carbogen; carbon dioxide; cerebral blood flow; end-tidal forcing; end-tidal targeting.

© The Author(s) 2016.

Figures

Figure 1.
Figure 1.
Two examples of circuits that apply a fixed inspired CO2 concentration. Circuit (a) uses a large reservoir of 5% CO2, 21% O2, balance N2, attached to a three-way valve. The position of the valve determines whether inspired gas is room air or the 5% CO2 mix. Circuit (b) applies a fixed CO2 concentration (0–5% CO2 in air or O2) at constant flow as gas input. During exhalation, the input gas fills an open-ended tube. This tube acts as a gas reservoir to make input gas available for inhalation when inspiratory flow exceeds gas input flow. This figure illustrates circuits similar to those used in Lu et al.+ and Tancredi et al.
Figure 2.
Figure 2.
The range of PetCO2 and PaCO2 in subjects breathing carbogen (5% CO2 in O2) from a circuit functionally identical to that shown in 1(A). Note the range of PetCO2 and PaCO2 with this constant inspired PCO2. Also note that when asked to hyperventilate (HV), the PetCO2 decreases to almost that of breathing ambient air, despite continuing to inspire 5% CO2. Data in blue from Prisman et al. in healthy subjects. Data in red from Baddeley et al. in patients administered carbogen intended as an adjuvant for effectiveness of radiotherapy for cancer.
Figure 3.
Figure 3.
The dynamic end-tidal forcing system adapted from Wise et al. O2, CO2, and N2 are blended breath-by-breath to provide the respective inspired gas concentrations. Inspired gas concentrations are calculated from the respective exhaled gas concentrations of the preceding breath and the target gas concentrations. High inspiratory flows are required to meet peak inspiratory flows. Gases are dry and require efficient humidification.
Figure 4.
Figure 4.
The prospective targeting system (RespirAct™). The system consists of a gas blender and a breathing circuit. Gas A is a blend of O2 and N2. Gas B is a blend of O2, and CO2 with balance N2. Gas C is O2. All gases contain O2 as a safety measure. A computer pre-calculates the breath-by-breath inspired gas concentrations and flow to attain end-tidal gas concentration targets and controls the gas blender delivery to a breathing circuit. The breathing circuit provides sequential gas delivery as follows. The subject exhales to the expiratory reservoir. During exhalation, the inspiratory reservoir fills with blended gas. On inspiration, the inspiratory reservoir is emptied and any additional gas is inhaled from the expiratory reservoir. Gas inhaled from the expiratory reservoir has already equilibrated with the blood and does not affect gas exchange, so that the gas inspired from the blender constitutes entirely of Va (see text). Thus, considering the alveolar gas equation (FetCO2 = FiCO2 + VCO2/Va), VCO2 is a user input function, and Va is imposed by the gas blender; control of these variables enables the targeting of FetCO2 and FetO2 independent of minute ventilation and breathing pattern. For further details see literatures.,,
Figure 5.
Figure 5.
Screen capture of sinusoidal changes in PetCO2 and PetO2 produced using the RespirAct™. (a) compressed time course; (b) expanded time course. Note the precise breath-to-breath changes and lack of breath-to-breath variability during the steady segments. Note also that changes in PetCO2 and PetO2 are independent of each other. Red tracing is tidal PCO2; blue dots are end-tidal values. Green tracing is tidal PO2; red dots are end-tidal values.
Figure 6.
Figure 6.
Screen capture of end-tidal targeting using RespirAct™. Simultaneous tracing from a step algorithm targeting sharp step changes in PCO2 and PO2. Typically (but not always) PCO2 transitions occur within 1–3 breaths. Red tracing is tidal PCO2; blue dots are end-tidal values. Green tracing is tidal PO2; red dots are end-tidal values.

References

    1. Reinhard M, Schwarzer G, Briel M, et al. Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease. Neurology 2014; 83: 1424–1431.
    1. Robbins PA, Swanson GD, Micco AJ, et al. A fast gas-mixing system for breath-to-breath respiratory control studies. J Appl Physiol 1982; 52: 1358–1362.
    1. Wise RG, Pattinson KT, Bulte DP, et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J Cereb Blood Flow Metab 2007; 27: 1521–1532.
    1. Slessarev M, Han J, Mardimae A, et al. Prospective targeting and control of end-tidal CO2 and O2 concentrations. J Physiol 2007; 581: 1207–1219.
    1. Fierstra J, Winter J, Machina M, et al. Non-invasive accurate measurement of arterial PCO2 in a pediatric animal model. J Clin Monit Comp 2013; 27: 147–155.
    1. Douglas CG, Haldane JS. The regulation of normal breathing. J Physiol 1909; 38: 420–440.
    1. Lu H, Liu P, Yezhuvath U, et al. MRI mapping of cerebrovascular reactivity via gas inhalation challenges. J Vis Exp 2014; 94. DOI: 10.3791/52306.
    1. Tancredi FB, Lajoie I, Hoge RD. A simple breathing circuit allowing precise control of inspiratory gases for experimental respiratory manipulations. BMC Res Notes 2014; 7: 235.
    1. Duffin J. Measuring the respiratory chemoreflexes in humans. Resp Physiol Neurbiol 2011; 177: 71–79.
    1. Mark CI, Slessarev M, Ito S, et al. Precise control of end-tidal carbon dioxide and oxygen improves BOLD and ASL cerebrovascular reactivity measures. Magn Reson Med 2010; 64: 749–756.
    1. Farhi LE, Rahn H. Dynamics of changes in carbon dioxide stores. Anesthesiology 1960; 21: 604–614.
    1. Jones NL, Robertson DG, Kane JW, et al. Effect of PCO2 level on alveolar-arterial PC02 difference during rebreathing. J Appl Physiol 1972; 32: 782–787.
    1. Prisman E, Slessarev M, Azami T, et al. Modified oxygen mask to induce target levels of hyperoxia and hypercarbia during radiotherapy: a more effective alternative to carbogen. Int J Radiat Biol 2007; 83: 457–462.
    1. Baddeley H, Brodrick PM, Taylor NJ, et al. Gas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures. Br J Radiol 2000; 73: 1100–1104.
    1. Fisher JA, Iscoe S and Duffin J. Sequential gas delivery provides precise control of alveolar gas exchange. Respir Physiol Neurobiol. Epub ahead of print 1 February 2016. DOI: 10.1016/j.resp.2016.01.004.
    1. Bulte DP, Chiarelli PA, Wise RG, et al. Cerebral perfusion response to hyperoxia. J Cereb Blood Flow Metab 2007; 27: 69–75.
    1. Ito S, Mardimae A, Han J, et al. Non-invasive prospective targeting of arterial PCO2 in subjects at rest. J Physiol 2008; 586: 3675–3682.
    1. Brogan TV, Robertson HT, Lamm WJ, et al. Carbon dioxide added late in inspiration reduces ventilation-perfusion heterogeneity without causing respiratory acidosis. J Appl Physiol 2004; 96: 1894–1898.
    1. Fierstra J, Machina M, Battisti-Charbonney A, et al. End-inspiratory rebreathing reduces the end-tidal to arterial PCO(2) gradient in mechanically ventilated pigs. Intensive Care Med 2011; 37: 1543–1550.
    1. Berry CB, Myles PS. Preoxygenation in healthy volunteers: a graph of oxygen “washin” using end-tidal oxygraphy. Br J Anaesth 1994; 72: 116–118.

Source: PubMed

3
구독하다